BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndrome With Excess Blasts-2 Intervention:   Drug: BXCL701 Sponsor:   Eric Stephen Winer, MD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials